The success of TAVR has also sparked research into transcatheter solutions for other valve diseases, including mitral and ...

Advocate Health Care heart patient Diana Esposito was recognized as the Chicago Bears’ special guest during the Bear Down ...

Objectives Older adults can have difficulties understanding and recalling information prior to hospitalisation for elective treatment. Limited research exists regarding how older adults perceive the ...

The Sapien M3 transcatheter mitral valve replacement system won FDA approval -- making it the first on the market to utilize ...

Edwards Lifesciences stock is supported by its growth outlook and the impact of clinical advances. See why investors should ...

HONG KONG, Dec. 12, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, ...

Edwards Lifesciences (NYSE: EW) + announced today that it provided the founding sponsorship for a new AHA Heart Valve Initiative. The American Heart Association (AHA) kicked off the Heart Valve ...

Edwards Lifesciences (NYSE: EW) today announced its founding sponsorship of the American Heart Association’s Heart Valve Initiative, a national effort to improve care and outcomes for the more than 28 ...

People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort from the American Heart Association designed to boost clinical trial ...